Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsu...
How could the lawsuit affect the company’s upcoming product pipeline announcements or trial timelines?
Are there any precedent cases involving similar securities fraud claims in the biotech sector that could guide expectations?
Will this lawsuit impact the company’s ability to recruit or retain key scientific and management personnel?
23 days ago